Stellar Biotechnologies Inc Share Price Toronto S.E.
Equities
KLH
CA85855A2039
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 14.76M 20.31M 1.23B |
---|---|---|---|---|---|
Net income 2024 * | -8M -11.01M -668M | Net income 2025 * | -10M -13.76M -835M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.35
x | P/E ratio 2025 * |
-2.76
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.08% |
Managers | Title | Age | Since |
---|---|---|---|
Pardeep Nijhawan
FOU | Founder | 53 | 12/07/12 |
Michael Brooks
PSD | President | 46 | 01/15/01 |
Stephen Lemieux
DFI | Director of Finance/CFO | 48 | 15/23/15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sean MacDonald
BRD | Director/Board Member | 47 | 07/19/07 |
Frank Oakes
BRD | Director/Board Member | 73 | 09/10/09 |
Patrick Marshall
BRD | Director/Board Member | 53 | 23/23/23 |
1st Jan change | Capi. | |
---|---|---|
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |